Wellbeing Whisper on MSN

FDA recall of blood pressure drug: What patients must know

More than 11,000 bottles of a widely prescribed blood pressure medication have been pulled from pharmacy shelves nationwide ...
Janesville Gazette

What's a 'black box' warning? A pharmacologist explains how these labels protect patients

THE CONVERSATION — A "black box" warning on a health product sounds pretty scary – maybe even more so when it's suddenly being taken off the packaging. Americans were reminded of this type of public ...
Reuters

Researchers move closer to matching patients with GLP-1 drug that works best for them

Data helps predict which drug will help specific patients lose weight Researchers used AI to analyze effect on patients’ other medical conditions Drug benefit-risk scores need to be developed, tested ...
The Business Journals

Gene therapy invented at Children's gets strongest FDA label after patient deaths

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA has restricted the type ...
Midland Daily News

What’s a ‘black box’ warning? A pharmacologist explains how these labels protect patients

(THE CONVERSATION) A “black box” warning on a health product sounds pretty scary – maybe even more so when it’s suddenly being taken off the packaging. Black box warnings – or as the FDA officially ...
Medical Xpress

Real-world responses reveal which patients benefit most from new schizophrenia drug

Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality. Now—just over a year ...
STAT

Alector’s dementia drug fails to slow patient decline in late-stage trial

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
The Washington Post

‘Dancing patients’ aren’t the biggest problem with drug ads

Steven Woloshin is a professor at the Dartmouth Institute for Health Policy and Clinical Practice and founder of the Lisa Schwartz Institute for Truth in Medicine. Baruch Fischhoff is a professor in ...
Wall Street Journal

Drug Rehabs Lure In Patients for Insurance Money—Then Leave Them on the Street

SIMI VALLEY, Calif.—Penny Lamb and Jeffery Lichtenberg were 1,500 miles from their home in Oklahoma with no money and no prospects when they were kicked out of their drug rehab program. None of it had ...
The American Journal of Managed Care

Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms

AmgenNow offers evolocumab at a reduced price, bypassing insurer requirements, and supports the Trump administration's drug pricing efforts. The Most Favored Nation executive order aims to align US ...